Breaks Categories: News

WednesdayMay 17, 2017 10:09 am

HempNewsBreaks – SinglePoint, Inc. (SING) Enters Letter of Intent to Acquire Stake in Discount Indoor Garden Supply

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its entry into a Letter of Intent with Discount Indoor Garden Supply (“DIGS”). Per the terms of the LOI, SinglePoint will acquire 90 percent of DIGS in a stock and cash transaction. The company anticipates that the acquisition will bring immediate revenues to SinglePoint while positioning it as a leader in online products, retail stores, cannabis consulting and equipment in California. “We are committed to identifying and making investments that will strengthen both parties' position in the cannabis industry while building SinglePoint's corporate value,” Greg Lambrecht, CEO of SinglePoint, stated…

Continue Reading

TuesdayMay 16, 2017 10:37 am

HempNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Adds Craig Cheifetz, M.D. to Advisory Team

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that Craig Cheifetz, M.D. has joined the company as an advisor to provide guidance on clinical trials, biotechnology, neuroscience, immunology and microbiology. “I welcome Dr. Cheifetz to the IGC advisory team and look forward to his contributions as we move forward in developing cannabis-based, combination therapies,” Ram Mukunda, CEO of IGC, stated in the news release. “We remain committed to accelerating our initiatives and building a robust portfolio of compounds to address large market conditions.” Cheifetz currently serves…

Continue Reading

WednesdayMay 10, 2017 1:58 pm

HempNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Extends Role of “Father of Marijuana Research” Raphael Mechoulam

In a news release issued early Tuesday, ABcann Global Corporation (TSXV: ABCN) announced that Raphael Mechoulam has agreed to extend his role as an advisor to the company. Aaron Keay, CEO and director of ABcann, spoke to the importance of this agreement in the news release. “Professor Mechoulam’s experience in medicinal cannabis is an invaluable resource for ABcann as we enter the most aggressive growth stage in the company’s history,” he stated. “The Company has invested heavily to build and extend its early leadership in advanced pharmaceutical-grade cannabis production. Professor Mechoulam’s advice, guidance, and unmatched expertise in the field has…

Continue Reading

WednesdayMay 10, 2017 9:39 am

HempNewsBreaks – InMed Pharmaceuticals (IMLFF) Announces Filing of Provisional Patent for INM-085

Pre-clinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) (CSE: IN) this morning announced the filing of a provisional patent application in the United States for INM-085 as a cannabinoid-based topical therapy for glaucoma. The company notes that this move marks an important step toward providing intellectual and commercial protection for INM-085. If approved, INM-085 could address an expansive global market that’s currently valued in excess of $5 billion. Per this morning’s update, glaucoma is currently the second-leading cause of blindness, driven by risk factors such as increased pressure in the eye, a family history of the condition, migraines, high…

Continue Reading

TuesdayMay 09, 2017 12:52 pm

HempNewsBreaks – Player’s Network, Inc. (PNTV) Announces Launch of Expanded Shareholder Communications Campaign

Diversified holding company Player’s Network, Inc. (OTCQB: PNTV) today announced the launch of a new, expanded shareholder communications and investor relations campaign aimed at broadening the company’s visibility in the investment community and providing added transparency to its shareholders by offering insight into all current operations and future plans. Introduction of the new campaign follows a significant spike in shareholder inquiries related to PNTV’s transition from developmental-stage holdings into operational, particularly as it relates to the company’s entry into the booming legal marijuana industry. “We have spent the last few months obsessing over revolutionary methods to better communicate with our…

Continue Reading

TuesdayMay 09, 2017 9:16 am

HempNewsBreaks – SinglePoint, Inc. (SING) Set to Begin Onboarding ‘High Risk’ Merchant Accounts

Specialized holding company Singlepoint, Inc. (OTC: SING) this morning announced its entry into a new agreement enabling the company to start onboarding ‘high risk’ merchant accounts. “We are providing multiple solutions to the cannabis space and we are trying to do the same in the payments space as well,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “Being able to offer a payment solution to multiple different verticals gives the company a larger target market to tap into. We believe high risk is a huge opportunity and an underserved market at this point.” The new solution will offer…

Continue Reading

FridayMay 05, 2017 12:18 pm

HempNewsBreaks – Eco Science Solutions, Inc. (ESSI) Inks LOI to Acquire Specialty Banking Operation; Shares Rise

Eco Science Solutions, Inc. (OTCQB: ESSI) shares are up more than 18% after the company this morning said it has signed a Letter of Intent (LOI) with Ga-Du Bank, Inc. for the purpose of acquiring full ownership of the bank in a stock and cash transaction. ESSI will operate the bank as a wholly owned subsidiary upon the closing of the transaction. Furthermore, the company will operate the financial banking division providing payment processing, cash management and financial services to its customers in the cannabis industry. "It has been our vision from day one that, in order to fully service…

Continue Reading

TuesdayMay 02, 2017 2:45 pm

HempNewsBreaks – Player’s Network, Inc. (PNTV) Launches Marijuana Accelerator Division

Diversified holding company Player’s Network, Inc. (OTCQB: PNTV) today announced the launch of a new division called Marijuana Accelerator following its acquisition of Marijuana Incubator. The launch of Marijuana Accelerator is part of PNTV’s overall strategy to gain market share by developing a national footprint in the legal medical marijuana industry. “The marijuana industry is lacking much-needed accelerator and incubator-style mentoring organizations, and we are pleased to present our unique solution to meet this need,” Brett H. Pojunis, member of PNTV’s board of directors, stated in today’s news release. “There is a lot of excitement in this industry. It reminds…

Continue Reading

TuesdayApr 25, 2017 1:28 pm

HempNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Announces Engagement of HempWire

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its engagement of HempWire (HW) for corporate communications solutions. HW is a multifaceted financial news and publishing company working to help public and private organizations find their voice and build market visibility by leveraging a rapidly expanding distribution network of more than 5,000 key syndication outlets. “We have an exciting pipeline of phytocannabinoid-based treatments based on our formulation for pain,” Ram Mukunda, CEO of IGC, stated in this morning’s news release. “As we move toward pre clinical and…

Continue Reading

MondayApr 10, 2017 10:01 am

HempNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Submits International Patent Applications for IGC-501

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has filed patent applications for IGC-501 in Canada, Israel and Europe in support of its ongoing cannabis-based combination therapy development initiatives. “We continue to strengthen our IP position in cannabis-based combination therapies and have progressed to include global patent filings,” Ram Mukunda, CEO of IGC, stated in the news release. “IGC is committed to addressing high potential international markets as a first mover in this emerging segment of cannabis-based combination therapy pharmaceuticals.” IGC-501 is being developed…

Continue Reading